Valuation: EXACT Therapeutics

Market Cap 4.43Cr 47.04L 41.93L 38.84L 35.32L 66.27L 45Cr 67.36L 4.66Cr 1.83Cr 23Cr 1.76Cr 1.73Cr 75Cr P/E 2024
-2.49x
P/E 2025 -1x
Enterprise Value 2.04Cr 21.64L 19.29L 17.87L 16.25L 30.49L 21Cr 30.99L 2.14Cr 84.28L 11Cr 81.19L 79.49L 34Cr EV / Sales 2024
-
EV / Sales 2025 1,07,44,37,000x
Free-Float
28.08%
Yield 2024 *
-
Yield 2025 -
1 day+40.56%
Current month-1.41%
1 month-10.83%
3 months-3.45%
6 months-54.25%
Current year-49.28%
1 month 0.43
Extreme 0.426
0.9
Current year 0.43
Extreme 0.426
2.7
1 year 0.43
Extreme 0.426
2.7
3 years 0.43
Extreme 0.426
15
5 years 0.43
Extreme 0.426
21
10 years 0.43
Extreme 0.426
53.59
Manager TitleAgeSince
Chief Executive Officer 66 06/06/2022
Chief Operating Officer - 01/01/2012
Director of Finance/CFO - 01/10/2022
Director TitleAgeSince
Chairman 55 22/06/2018
Chairman - 08/06/2022
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap. Importance
04/01/23 Buy

Chairman

2,500 0.0083%
04/01/23 Buy

Founder

2,500 0.0083%
04/01/23 Buy

Chief Financial Officer

2,500 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
+40.56%0.00%-62.57%-95.33% 46.9L
+1.52%-7.16%+51.66%+67.41% 6.5TCr
+1.52%+6.83%+10.89%+79.30% 5.12TCr
+0.30%-0.46%-0.03%+61.89% 5.12TCr
-0.83%+0.79%+24.63%+41.51% 4.39TCr
+0.67%+6.12%+16.71%+134.34% 4.2TCr
+2.29%-6.24%+236.68%+527.03% 3.81TCr
+2.16%+10.36%+18.92%+59.70% 3.32TCr
-0.90%-10.49%+37.09%+1.80% 2.52TCr
+1.60%+2.21%+27.96%+28.00% 2.25TCr
Average +4.85%+0.50%+36.19%+90.56% 3.72TCr
Weighted average by Cap. +0.91%+0.04%+45.43%+112.34%

Financials

2024 2025
Net sales - 0.06 0.01 0.01 0.01 0 0.01 0.59 0.01 0.06 0.02 0.31 0.02 0.02 0.99
Net income -5.23Cr -55.59L -49.55L -45.9L -41.73L -78.31L -53Cr -79.6L -5.51Cr -2.16Cr -28Cr -2.09Cr -2.04Cr -88Cr -8.7Cr -92.38L -82.35L -76.28L -69.36L -1.3Cr -88Cr -1.32Cr -9.15Cr -3.6Cr -46Cr -3.47Cr -3.39Cr -146.33Cr
Net Debt -9.89Cr -1.05Cr -93.63L -86.74L -78.86L -1.48Cr -100Cr -1.5Cr -10Cr -4.09Cr -52Cr -3.94Cr -3.86Cr -166.39Cr -2.39Cr -25.4L -22.64L -20.97L -19.07L -35.78L -24Cr -36.37L -2.52Cr -98.92L -13Cr -95.3L -93.3L -40Cr
Projected Income Statement - Annual - EXACT Therapeutics
Logo EXACT Therapeutics
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
Employees
11
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. EXTX Stock